Metrikler
Yayın
18
Açık Erişim
3
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2018 - 2021
2018 - 2021Tıpta Yandal Uzmanlık
Dicle Üniversitesi, Tıp Fakültesi, Onkoloji, Türkiye
2012 - 2016
2012 - 2016Tıpta Uzmanlık
Van Yüzüncü Yıl Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2001 - 2008
2001 - 2008Lisans
Van Yüzüncü Yıl Üniversitesi, Tıp Fakültesi, Türkiye
Araştırma Alanları
Sağlık Bilimleri
Akademik Unvanlar / Görevler
2023 - Devam Ediyor
2023 - Devam EdiyorDr. Öğr. Üyesi
Van Yüzüncü Yıl Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
2025
20251. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Sezgin Y., Karhan O., Aldemir M. N., Ürün M., Erçek B. M., Urakcı Z., et al.
Scientific Reports
, cilt.15, sa.1, 2025 (SCI-Expanded)
2025
20252. Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study
Karhan O., İleri S., Urakçl Z., Arvas H., Klllç D. K., Sezgin Y., et al.
Oncology (Switzerland)
, cilt.103, sa.6, ss.498-507, 2025 (SCI-Expanded)
2024
20243. Prognostic Significance of the Advanced Lung Cancer Inflammation Index in Metastatic Small Cell Lung Cancer: A Retrospective Analysis of 96 Patients
Ürün M., Güner G., Sezgin Y., Uysal E., SAKİN A., Kilickap S.
Medical Science Monitor
, cilt.30, 2024 (SCI-Expanded)
2024
20244. Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience
Sezgin Y., Karhan O., Ileri S., Ebinc S., Tunc S., Urakci Z.
Journal of the College of Physicians and Surgeons Pakistan
, cilt.34, sa.8, ss.904-909, 2024 (SCI-Expanded)
2024
20245. Mesenteric Panniculitis as a Side Effect of Nivolumab in a Patient with Larnyngeal Cancer
Karhan O., Sezgin Y., Ileri S., Tunc S.
Nigerian journal of clinical practice
, cilt.27, sa.6, ss.800-803, 2024 (SCI-Expanded)
2024
20246. Association Between Body Mass Index and Survival in Patients with De Novo Metastatic Non-Small Cell Lung Cancer
Ürün M., Güner G., Sezgin Y., SAKİN A., Kılıçkap S.
Medical Science Monitor
, cilt.30, 2024 (SCI-Expanded)
2024
20247. Caffeine mitigates tamoxifen-induced fatty liver in Wistar rats
Sezgin Y., Bora E. S., Arda D. B., UYANIKGİL Y., Erbaş O.
Acta cirurgica brasileira
, cilt.39, 2024 (SCI-Expanded)
2023
20238. Are Syrian refugee breast cancer patients diagnosed at advanced stage and do they have treatment delays?
Karhan O., Secmeler Ş., Sezgin Y., Ileri S., Yerlikaya H.
Future Oncology
, cilt.19, sa.14, ss.983-989, 2023 (SCI-Expanded)
2022
20229. Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapy
Ebinç S., Oruç Z., Sezgin Y., Karhan O. u., Bilen E., Yerlikaya H., et al.
Future Oncology
, cilt.18, sa.30, ss.3399-3408, 2022 (SCI-Expanded)
2020
202010. The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort
Karaağaç M., Sezgin Y., Eryılmaz M. K., Araz M., Kaplan M. A., Artaç M.
Journal of Oncology Pharmacy Practice
, cilt.26, sa.7, ss.1657-1666, 2020 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
2025
20251. The Role of Bıomarkers In Predıctıng Neoadjuvant Treatment Response In Gastrıc Cancer
Sezgin Y., Ürün M.
Eastern Journal of Medicine
, cilt.30, sa.2, ss.245-255, 2025 (Scopus)
2024
20242. Testis Kanserinde Prognostik Faktörler
Sezgin Y., Karhan O., Biçer A., İleri S., Yerlikaya H., Tunç S., et al.
Turkish Journal of Clinics and Laboratory
, cilt.15, sa.2, ss.176-181, 2024 (Hakemli Dergi)
2024
20243. Comparison of the Efficacy of Dual Chemotherapy Regimens in Second-Line Treatment of Metastatic Esophageal Squamous Cell Carcinoma
Guner G., Sezgin Y.
Eurasian Journal of Medical Investigation
, cilt.8, sa.1, ss.48-53, 2024 (Hakemli Dergi)
2023
20234. The impact of timing adjuvant therapy on disease-free survival among patients with stage iib-iiia non-small cell lung cancer receiving platinum- based treatment
ÜRÜN M., SEZGİN Y., UYSAL E.
Turkish Journal of Clinics and Laboratory
, cilt.14, sa.3, ss.639-644, 2023 (Hakemli Dergi)
2023
20235. Comparison of the Efficacy of FOLFIRI and Paclitaxel Chemotherapy Regimens in the Second Line Treatment of Metastatic Gastric Cancer
ÜRÜN M., GÜNER G., SEZGİN Y., YILMAZ ÜRÜN Y., SAKİN A.
Van Yuzuncu Yil University , cilt.16, sa.2, ss.176-182, 2023 (Hakemli Dergi)
2023
20236. ADDITIONAL COST OF OVERWEIGHT IN MEDICATION OF CANCER PATIENTS
ÜRÜN M., SEZGİN Y., YILMAZ ÜRÜN Y., UÇAN A., GÜRCÜ S., TUĞRUL F.
Eskisehir Medical Journal, Eskisehir City Hospital , cilt.4, sa.2, ss.107-110, 2023 (Hakemli Dergi)
2023
20237. The Prediction of Overall Survival With The Use of The Sarculator In Operated Soft Tissue Sarcoma of The Extremities: Monocentre Experience
Sezgin Y., Karhan O.
Eastern Journal of Medicine
, cilt.28, sa.4, ss.804-809, 2023 (Scopus)
2022
2022